Trump Will Announce Medicaid Drug Pricing Policy Changes
The new policy will provide all 50 states access to most favored nation pricing for certain prescription drugs.
Updated on Sept. 18, 2026 in Economic Policy
Live Poll
Should the federal government regulate prescription drug prices to reduce costs for patients?
President Trump is set to announce a new policy on September 19, 2026, targeting prescription drug costs within state Medicaid programs. The change aims to provide all 50 states with access to most favored nation pricing for specific medications.
Why it matters
This policy shift addresses long-standing concerns regarding prescription drug affordability for households that rely on Medicaid benefits. The announcement arrives as policymakers seek to mitigate healthcare costs for voters.
The policy change will apply to 50 states nationwide to help curb prescription costs. While the scale of potential savings remains unknown, the administration has signaled that Medicaid will gain access to most favored nation pricing for selected drugs.
The players
President Donald Trump
The current President of the United States who is directing federal executive policy on healthcare and drug pricing.
The details
By adopting most favored nation pricing, the administration aims to link the price Medicaid programs pay for certain drugs to the lowest prices available internationally. This mechanism is designed to exert downward pressure on the costs that state programs incur when procuring medications for beneficiaries. By aggregating market power across all 50 states, the policy intends to reduce the financial burden of high-cost prescriptions on public health budgets.
Timeline
September 19, 2026, at 2:30 p.m. EDT.
Money Landscape
This move represents a continued federal effort to curb rising pharmaceutical expenditures across public insurance programs. It builds upon the precedent set by the Inflation Reduction Act's Medicare drug-price negotiation provisions by expanding price-control mechanisms into the Medicaid sphere.
Households enrolled in Medicaid should monitor their plan materials for changes in drug coverage or out-of-pocket costs resulting from this national policy shift. Consult with a qualified financial or tax professional to understand how shifts in public healthcare policy may impact your long-term medical budgeting.
The takeaway
The implementation of most favored nation pricing aims to lower costs for state Medicaid programs, potentially stabilizing public health expenditures. Track the specific drug lists released following the announcement to see if your own medications are affected by the new pricing structure.
What happens next
President Trump is scheduled to deliver remarks in the Oval Office at 2:30 p.m. EDT on September 19, 2026.
Further reading
For more background on how government actions influence healthcare expenses, visit the Economic Policy section.
Live Poll
Should the federal government regulate prescription drug prices to reduce costs for patients?
